TGFB1 and neoplasm: Furthermore, LAG-3 marks Tregs releasing immunosuppressive cytokines, such as IL-10 and TGF-β1, with a more suppressive phenotype than LAG-3-negative cells from the tumour sites of cancer patients [61].